Akoya BioSciences Inc (AKYA) Optionen

TL;DR. You can can it with the walls of AI text that nobody reads. This is dead for now. See you next year. Maybe. Again.

You didn’t discuss the reg, you simply inferred she could be charged with other things.

Brace: annual financials in 2 days !!!

https://investorshub.advfn.com/uimage/uploads/2025/3/10/vjyjnIMG_0330.jpeg

Pulte & Bessent continue to fight shareholders in court:

https://x.com/GuidoPerei/status/1906388157295460417

HAPPY SUNDAY AND TO ALL

GL...

HI THERE 02 AND ALL

I'm aware of that but that still leaves 4 more which is insane for a week let alone a game, but at the end of the day the pitchers is part of the team errors as well. But end result is I'm more forgiving of pitchers errors, they have to pitch and are generally in a compromised position to field the

https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1cqursl*_gcl_au*OTA1MjAwNDc2LjE3NDExMTYwODY.
HELLO THIS IS BIG D !! THE MAN HERE !! WELL I GOT SUCKED INTO BUYING ONE MILLION MORE SHARES AT 300 $ TODAY !! THAT MAKES MY POSITION A VERY SOUR ONE !!! 111 MILLION (BE

https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1cqursl*_gcl_au*OTA1MjAwNDc2LjE3NDExMTYwODY.
HELLO THIS IS BIG D !! THE MAN HERE !! WELL I GOT SUCKED INTO BUYING ONE MILLION MORE SHARES AT 300 $ TODAY !! THAT MAKES MY POSITION A VERY SOUR ONE !!! 111 MILLION (BE

Smitty you are not alone. Keep posting. Let’s let management know we have had it with their lack of progress and very questionable investments in private cdmos

Remember where that is coming from. This dude only reads the funny papers for his news. He only cuts and paste stories that has nothing to do with the company at hand. He has no idea a company's filings of understand a PR... Most of everything he posts are made up BS fairy tales....

Smitty you are not alone. Keep posting. Let’s let management know we have had it with their lack of progress and very questionable investments in private cdmos

NVDA Nvidia - The following two weeks have historically brought back-to-back losses...
By: TrendSpider | March 30, 2025

• Nvidia is staring down one of its weakest stretches of the year. The following two weeks have historically brought back-to-back losses, with seasonal h

Ok, but even 10% of revenue is significant,if it disappeared. Expectstions for NVDA are always high. Even when NVDA beats earnings and expectations, the price still drops, on occasion. So an actual 10% decline in revenue would be significant.

What I am saying is that there won't be a

Oh No, not the iggy button, lol...🖕

its criminal for sure. But the initial Class-Actions by shareholders would obviously be a civil matter. And as such, more easily won as it doesn't have to be a reasonable doubt and civil relies of "preponderance of the evidence," meaning it's more likely than not that the claim is true. I think this

1 follower, that's it? 🙈😂😭

So sorry you had trouble with that -- here let me help you

the chat "inferred" there were humint on the ground in Yemen
====
What does inferred mean in simple terms?
When you infer something, you read between the lines. To infer is to make a well informed guess

Falconer
How about contacting Wisner Baum or Morgan and Morgan law firms instead. Never know what you’ll get by asking to speak to the
Office Manager to explain your good intentions. Have done it myself to get in touch with some very private people over my career. Check it out here…

I sold 80% of my lwlg holdings im dec. And jan. After the confusing and vaque communication. Bought back a lot last week and more is to come if the shareprice decreases or stays at this level.

OK DD, I've read the thread. I can accept the issues you've raised, provided you will agree that both Powers and Boyton are attorneys and have more knowledge re SEC regs and dealing with them than either you or myself.
So why haven't you filed a complaint if you're adamant they have multiple

Yes, I saw that interview, and enjoyed listening to it.

Chose your pick and make it happen

Novartis

Bristol Myers Squibb

AstraZeneca

Merck

AbbVie

Johnson & Johnson

Roche Diagnostics

Eli Lilly

Amgen

Pfizer

The cool thing about having Eontec in the East and lqmt in the West is it makes sense to drive the PO through the company where the sale originates. This is what has happened in China.

I expect with STRONG probability that Li will run the US based Amphenol PO through US based lqmt